Shionogi To Launch Research Support Subsidiary
This article was originally published in PharmAsia News
Executive Summary
Shionogi will launch a clinical research support company, Techno Advance Research, in Japan in September to strengthen pharmacological and safety evaluation for new drug development. The wholly owned subsidiary will have a staff of 50. Starting this year, Shionogi begins implementing its third mid-term business strategy, which calls for an enhanced research system to enable continuous discovery of new chemical compounds. (Click here for more - Japanese language
Shionogi will launch a clinical research support company, Techno Advance Research, in Japan in September to strengthen pharmacological and safety evaluation for new drug development. The wholly owned subsidiary will have a staff of 50. Starting this year, Shionogi begins implementing its third mid-term business strategy, which calls for an enhanced research system to enable continuous discovery of new chemical compounds. (Click here for more - Japanese language) "Shionogi Transfer Antibiotic Marketing To Bayer Yakuhin"--Chemical Daily (5/11/2010) |